Detalhe da pesquisa
1.
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Cancer Immunol Immunother
; 73(2): 34, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280067
2.
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.
Res Sq
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886483
3.
The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A retrospective cohort study.
Medicine (Baltimore)
; 99(52): e23861, 2020 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350780
4.
Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
Cells
; 8(6)2019 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181818
5.
A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment.
Eur J Rheumatol
; 5(2): 111-114, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185359
6.
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
Intern Med
; 56(17): 2271-2275, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794381
7.
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
Intern Med
; 56(8): 903-906, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420837
8.
Comparative Study of Infliximab Therapy and Methotrexate Monotherapy to Improve the Clinical Effect in Rheumatoid Arthritis Patients.
Intern Med
; 55(18): 2581-5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629950